MRI of the breast for optimal selection of patients with a preoperative diagnosis of ductal carcinoma in situ for a sentinel node biopsy procedure

MRI of the breast for optimal selection of patients with a preoperative diagnosis of ductal carcinoma in situ for a sentinel node biopsy procedure - MRI in patients with DCIS of the breast

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36570

Enrollment

150

Registered

2011-10-28

Start date

2012-04-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast preneoplasia ductal carcinoma in situ

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women > 25 years of age with biopsy proven DCIS are eligible for this study.

Exclusion criteria

Exclusion criteria: • claustrophobia, obesity (too big to fit into gantry of the MR system), large breast cup size (too big to fit into the coil) • pacemaker • known inflammatory diseases (RA, SLE, sarcoidosis, psoriasis) since these can cause reactive axillary lymfadenopathy • pregnancy • biopsy proven invasive carcinoma in the same breast; invasive carcinoma in the contra lateral breast is not an exclusion criterion. • poor health excluding an operative procedure - renal failure

Design outcomes

Primary

Measure	Time frame
Predictive value of MRI and selected tissue markers on the presence of IDC	—

Secondary

Measure	Time frame
Accuracy of MRI in determining the extent of DCIS compared to mammography. The size as determined by pathological examination will be the gold standard	—

Countries

Netherlands

Outcome results